Brief Report: Rapid Clinical Recovery From Critical Coronavirus Disease 2019 With Respiratory Failure in a Pregnant Patient Treated With IV Vasoactive Intestinal Peptide

Aviptadil, a synthetic form of human vasoactive intestinal peptide, has entered clinical trials to treat critical coronavirus disease 2019 pneumonia with respiratory failure. Vasoactive intestinal peptide protects the lung against a broad array of injuries by binding to the vasoactive intestinal pep...

Descripción completa

Detalles Bibliográficos
Autores principales: Youssef, Jihad Georges, Bitar, Mohammad Z., Zahiruddin, Faisal, Al-Saadi, Mukhtar, Elshawwaf, Mahmoud, Yau, Simon, Goodarzi, Ahmad, Javitt, Jonathan C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8735760/
https://www.ncbi.nlm.nih.gov/pubmed/35018346
http://dx.doi.org/10.1097/CCE.0000000000000607

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8735760/
https://www.ncbi.nlm.nih.gov/pubmed/35018346
http://dx.doi.org/10.1097/CCE.0000000000000607

Ejemplares similares